Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (ES 434/8-1)
Innovative Medicines Initiative (820820)
Bayerisches Staatsministerium für Wirtschaft, Infrastruktur, Verkehr und Technologie (Medical Valley Award 2017)
Received: 24 February 2021
Accepted: 20 May 2021
First Online: 3 June 2021
: The study was approved by the local ethics committee Re-No. 165_18B (Friedrich-Alexander-University Erlangen-Nuremberg, Germany). All patients gave written, informed consent, prior to the data collection,
: Not applicable.
: The authors declare that they have no competing interests.